Acute Caffeine Ingestion on Futsal Performance (CAFFFUTSAL)

April 19, 2021 updated by: Universidad Francisco de Vitoria

Effects of Acute Caffeine Ingestion on Futsal Performance in Sub-elite Players

Caffeine supplementation has been recognized such as an useful strategy for improving performance in intermittent sports, however caffeine ingestion in futsal has been barely studied. In this randomized placebo-controlled study, we investigated the effects of acute caffeine supplementation in improving neuromuscular performance and physical match activity in futsal players.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

To date, no previous investigation has studied the effect of acute caffeine ingestion on futsal performance during futsal-specific testing and during a simulated match. Therefore, the aim of this investigation was to establish the effects of acute caffeine intake on futsal-specific tests (e.g. futsal kicking velocity) and match-play running performance in male futsal players.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Madrid, Spain, 28223
        • Universidad Francisco de Vitoria

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 33 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Sub-elite men futsal players

Exclusion Criteria:

  • Intolerance to caffeine,
  • Suffering from any chronic pathology or an injury in the month prior to the investigation
  • Use of medicines or dietary supplements during the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo supplementation
Acute placebo supplementation
Dietary supplement: Placebo
Gelatine capsule with placebo (Cellulose; Guinama, Valencia, Spain). The capsule containing the treatment was ingested with 150 mL of water 60 minutes before the onset of the experiment to allow substance absorption.
Experimental: Caffeine supplementation
Acute caffeine supplementation
Dietary supplement: Caffeine
Gelatine capsule with caffeine (3 mg/kg body mass of caffeine) (Bulk Powders, London, United Kingdom). The capsule containing the treatment was ingested with 150 mL of water 60 minutes before the onset of the experiment to allow substance absorption.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in futsal match-play demands (m/min)
Time Frame: 48-hours
Using a wireless inertial movement unit system
48-hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in maximal jump height (cm)
Time Frame: 48-hours
Infrared beam jump system
48-hours
Changes in 20-m sprint test (s)
Time Frame: 48-hours
Time to complete 10-m and 20-m sprints using photocell timing gates
48-hours
Futsal kicking velocity and accuracy test (km/h)
Time Frame: 48-hours
Throwing velocity using a radar gun
48-hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Francisco de Vitoria

Collaborators

Universidad Miguel Hernandez de Elche
Universidad Rey Juan Carlos
University of Beira Interior

Investigators

  • Principal Investigator: Alvaro L López Samanes, PhD, Universidad Francisco de Vitoria

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 16, 2019

Primary Completion (Actual)

October 18, 2019

Study Completion (Actual)

October 18, 2019

Study Registration Dates

First Submitted

April 19, 2021

First Submitted That Met QC Criteria

April 19, 2021

First Posted (Actual)

April 21, 2021

Study Record Updates

Last Update Posted (Actual)

April 21, 2021

Last Update Submitted That Met QC Criteria

April 19, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Universidad Francisco Vitoria

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caffeine

Clinical Trials on Caffeine

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe